» Articles » PMID: 19770518

Pin1 Regulates Parathyroid Hormone MRNA Stability

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2009 Sep 23
PMID 19770518
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Secondary hyperparathyroidism often occurs in chronic kidney disease (CKD) and vitamin D deficiency, resulting in increased fractures and mortality. Understanding factors that stimulate parathyroid hormone (PTH) synthesis is important for devising methods to treat this condition. Previous work has demonstrated that murine Pth mRNA levels are regulated by proteins that bind AU-rich elements (AREs) within the 3' UTR region of Pth mRNA and influence Pth mRNA stability. In this issue of the JCI, Nechama et al. demonstrate that in murine secondary hyperparathyroidism associated with CKD or Ca deficiency, the activity of Pin1, a peptidyl-prolyl isomerase, is reduced (see the related article beginning on page 3102). Reduced Pin1 activity resulted in the phosphorylation and degradation of an ARE-binding protein, K-homology splicing regulator protein (KSRP), which normally enhances the degradation of Pth mRNA. The activity of other ARE-binding proteins, such as AU-rich binding factor 1 (AUF1), that increase Pth mRNA stability, was increased, thereby increasing PTH synthesis. This work suggests new ways by which to regulate PTH synthesis in secondary hyperparathyroidism.

Citing Articles

The molecular mechanisms of peptidyl-prolyl isomerase Pin1 and its relevance to kidney disease.

Wu S, Zou Y, Tan X, Yang S, Chen T, Zhang J Front Pharmacol. 2024; 15:1373446.

PMID: 38711994 PMC: 11070514. DOI: 10.3389/fphar.2024.1373446.


The PIN1-YTHDF1 axis promotes breast tumorigenesis via the mA-dependent stabilization of AURKA mRNA.

Shrestha P, Kim G, Kang H, Bhattarai P, Choi H Arch Pharm Res. 2023; 47(1):66-81.

PMID: 38147203 DOI: 10.1007/s12272-023-01480-z.


K-Homology Type Splicing Regulatory Protein: Mechanism of Action in Cancer and Immune Disorders.

Leavenworth J, Yusuf N, Hassan Q Crit Rev Eukaryot Gene Expr. 2023; 34(1):75-87.

PMID: 37824394 PMC: 11003564. DOI: 10.1615/CritRevEukaryotGeneExpr.2023048085.


Molecular Mechanisms of Parathyroid Disorders in Chronic Kidney Disease.

Hassan A, Khalaily N, Kilav-Levin R, Nechama M, Volovelsky O, Silver J Metabolites. 2022; 12(2).

PMID: 35208186 PMC: 8878033. DOI: 10.3390/metabo12020111.


RNA-binding proteins and their role in kidney disease.

Seufert L, Benzing T, Ignarski M, Muller R Nat Rev Nephrol. 2021; 18(3):153-170.

PMID: 34732838 DOI: 10.1038/s41581-021-00497-1.


References
1.
Schiavi S, Belasco J, Greenberg M . Regulation of proto-oncogene mRNA stability. Biochim Biophys Acta. 1992; 1114(2-3):95-106. DOI: 10.1016/0304-419x(92)90009-n. View

2.
Audran M, Gross M, Kumar R . The physiology of the vitamin D endocrine system. Semin Nephrol. 1986; 6(1):4-20. View

3.
Moe S, Drueke T . Management of secondary hyperparathyroidism: the importance and the challenge of controlling parathyroid hormone levels without elevating calcium, phosphorus, and calcium-phosphorus product. Am J Nephrol. 2003; 23(6):369-79. DOI: 10.1159/000073945. View

4.
Hofer A, Brown E . Extracellular calcium sensing and signalling. Nat Rev Mol Cell Biol. 2003; 4(7):530-8. DOI: 10.1038/nrm1154. View

5.
Kilav R, Bell O, Le S, Silver J, Naveh-Many T . The parathyroid hormone mRNA 3'-untranslated region AU-rich element is an unstructured functional element. J Biol Chem. 2003; 279(3):2109-16. DOI: 10.1074/jbc.M305302200. View